Epidemiology and clinical characteristics of Klebsiella spp. meningitis in France

Infect Dis Now. 2022 Mar;52(2):82-86. doi: 10.1016/j.idnow.2021.05.006. Epub 2021 Jun 6.

Abstract

Objectives: To describe the epidemiology of Klebsiella spp. meningitis in France with respect to clinical and bacteriological data.

Methods: We performed a four-year multicenter, retrospective, observational study. The primary objective was to provide a clinical description of patients with Klebsiella spp. meningitis. Secondary objectives were to compare community-acquired meningitis and healthcare-associated meningitis and to analyze factors associated with mortality.

Results: We enrolled 131 patients with Klebsiella spp. meningitis. Eighty-two (62.6%) infections were reported following neurosurgery. Twenty-eight strains (21.4%) were resistant to third-generation cephalosporins (3GC). The median [IQR] cellularity was 980/mm3 [116-5550], the median protein level was 5.67 [1.62-9] g/L and the median CSF glucose level was 2.5 [0-3.4] mmol/L. The in-hospital mortality rate was 23.6%. Community-acquired meningitis isolates were more frequently susceptible to 3GC than isolates from healthcare-associated meningitis (89.2% versus 72%; P=0.04). Comorbidities reported for patients with community-acquired meningitis were mainly diabetes mellitus and liver cirrhosis. In multivariate analysis, focal neurological disorder at the time of diagnosis was the only factor associated with in-hospital mortality (P=0.01).

Conclusions: Purulent meningitis caused by Klebsiella spp. needs to be considered in patients with community-acquired meningitis and preexisting conditions, as well as in case of meningitis following neurosurgical procedures.

Keywords: Klebsiella pneumoniae; Meningitis; Neurosurgery; Nosocomial infection.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • France / epidemiology
  • Humans
  • Klebsiella
  • Klebsiella Infections* / complications
  • Klebsiella Infections* / drug therapy
  • Klebsiella Infections* / epidemiology
  • Meningitis, Bacterial* / complications
  • Meningitis, Bacterial* / drug therapy
  • Meningitis, Bacterial* / epidemiology
  • Retrospective Studies